FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200012968> ?p ?o ?g. }

• W4200012968 endingPage "153873" @default.
• W4200012968 startingPage "153873" @default.
• W4200012968 abstract "Chinese herbal medicine (CHM) has been used as adjuvant treatment of chronic kidney disease (CKD) for years. Astragalus membranaceus (A. membranaceus, Huangqi [A]), Angelica sinensis (Oliv.) Diels (Danggui [S]), Rheum palmatum L. (Dahuang [R]), and Salvia miltiorrhiza Bunge (Danshen [D]) are considered as potentially renoprotective CHMs. However, there is limited evidence on whether ASRD use affects outcomes and causes hyperkalemia in patients with stage 4 and stage 5 advanced CKD.To investigate between ASRD use (vs. nonuse) and risks of end-stage renal disease (ESRD), death, and hyperkalemia in patients with advanced CKD.Retrospective nationwide cohort study using claims data from the Taiwan's 2005 Longitudinal Generation Tracking Database in 2000-2016.A total of 24,572 patients with advanced CKD were identified and 15,729 eligible patients were enrolled in the propensity score matching, with 1,401 incident ASRD users (8.9%) and 14,328 nonusers (91.1%). Finally, 1,076 ASRD users and 4,304 matched nonusers were subjected to analysis. We used Cox proportional hazards regression model to estimate the hazard ratios for ESRD and death and Poisson regression to estimate incidence rate ratio of hyperkalemia. The additive effect of one to four ASRD and the pooling effect of individual ASRD on risks of ESRD and death were also addressed.In a total follow-up of 15,740 person-years, 2,703 patients (50.2%) developed ESRD and 499 (9.3%) died before progression to ESRD. As compared with nonusers, ASRD users were associated with adjusted hazard ratios of 0.83 (95% confidence interval, 0.76-0.91) for ESRD and 0.78 (0.30-0.93) for death, as well as adjusted incidence rate ratios of 0.54 (0.48-0.60) for inpatient hyperkalemia and 0.44 (0.42-0.46) for total hyperkalemia. The renal and survival benefits of ASRD use were consistent across almost patient subgroups on multivariate stratified analyses. Using all four ASRD provided the lowest risks of ESRD (0.30; 0.71-0.52) and death (0.32; 0.17-0.63). Individual use of ASRD also demonstrated comparable renal and survival benefits.ASRD use was associated with lower risks of ESRD and death among advanced CKD patients. This benefit did not increase hyperkalemia risk." @default.
• W4200012968 created "2021-12-31" @default.
• W4200012968 creator A5018195831 @default.
• W4200012968 creator A5041507817 @default.
• W4200012968 creator A5046312756 @default.
• W4200012968 creator A5077889559 @default.
• W4200012968 creator A5089427275 @default.
• W4200012968 date "2022-01-01" @default.
• W4200012968 modified "2023-10-07" @default.
• W4200012968 title "Four prescribed Chinese herbal medicines provide renoprotection and survival benefit without hyperkalemia risk in patients with advanced chronic kidney disease: A nationwide cohort study" @default.
• W4200012968 cites W1107021872 @default.
• W4200012968 cites W1567051068 @default.
• W4200012968 cites W1918700904 @default.
• W4200012968 cites W1965675690 @default.
• W4200012968 cites W1967595103 @default.
• W4200012968 cites W1970719176 @default.
• W4200012968 cites W1975047879 @default.
• W4200012968 cites W1988851807 @default.
• W4200012968 cites W2014648882 @default.
• W4200012968 cites W2022704774 @default.
• W4200012968 cites W2028838817 @default.
• W4200012968 cites W2037653795 @default.
• W4200012968 cites W2038229511 @default.
• W4200012968 cites W2044186731 @default.
• W4200012968 cites W2044349000 @default.
• W4200012968 cites W2046296664 @default.
• W4200012968 cites W2058605561 @default.
• W4200012968 cites W2085746985 @default.
• W4200012968 cites W2087344722 @default.
• W4200012968 cites W2098364806 @default.
• W4200012968 cites W2116836111 @default.
• W4200012968 cites W2130193896 @default.
• W4200012968 cites W2130462820 @default.
• W4200012968 cites W2159657555 @default.
• W4200012968 cites W2165912423 @default.
• W4200012968 cites W2167447251 @default.
• W4200012968 cites W2260779715 @default.
• W4200012968 cites W2614680263 @default.
• W4200012968 cites W2736033499 @default.
• W4200012968 cites W2887645829 @default.
• W4200012968 cites W2888565440 @default.
• W4200012968 cites W2891652983 @default.
• W4200012968 cites W2940893790 @default.
• W4200012968 cites W2942080882 @default.
• W4200012968 cites W2943005888 @default.
• W4200012968 cites W3035320048 @default.
• W4200012968 cites W3126378467 @default.
• W4200012968 cites W3145659568 @default.
• W4200012968 doi "https://doi.org/10.1016/j.phymed.2021.153873" @default.
• W4200012968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34896898" @default.
• W4200012968 hasPublicationYear "2022" @default.
• W4200012968 type Work @default.
• W4200012968 citedByCount "10" @default.
• W4200012968 countsByYear W42000129682022 @default.
• W4200012968 countsByYear W42000129682023 @default.
• W4200012968 crossrefType "journal-article" @default.
• W4200012968 hasAuthorship W4200012968A5018195831 @default.
• W4200012968 hasAuthorship W4200012968A5041507817 @default.
• W4200012968 hasAuthorship W4200012968A5046312756 @default.
• W4200012968 hasAuthorship W4200012968A5077889559 @default.
• W4200012968 hasAuthorship W4200012968A5089427275 @default.
• W4200012968 hasBestOaLocation W42000129681 @default.
• W4200012968 hasConcept C126322002 @default.
• W4200012968 hasConcept C207103383 @default.
• W4200012968 hasConcept C2778653478 @default.
• W4200012968 hasConcept C2779134260 @default.
• W4200012968 hasConcept C2780243291 @default.
• W4200012968 hasConcept C3019040382 @default.
• W4200012968 hasConcept C44249647 @default.
• W4200012968 hasConcept C50382708 @default.
• W4200012968 hasConcept C71924100 @default.
• W4200012968 hasConcept C72563966 @default.
• W4200012968 hasConceptScore W4200012968C126322002 @default.
• W4200012968 hasConceptScore W4200012968C207103383 @default.
• W4200012968 hasConceptScore W4200012968C2778653478 @default.
• W4200012968 hasConceptScore W4200012968C2779134260 @default.
• W4200012968 hasConceptScore W4200012968C2780243291 @default.
• W4200012968 hasConceptScore W4200012968C3019040382 @default.
• W4200012968 hasConceptScore W4200012968C44249647 @default.
• W4200012968 hasConceptScore W4200012968C50382708 @default.
• W4200012968 hasConceptScore W4200012968C71924100 @default.
• W4200012968 hasConceptScore W4200012968C72563966 @default.
• W4200012968 hasFunder F4320310848 @default.
• W4200012968 hasFunder F4320335906 @default.
• W4200012968 hasFunder F4320336177 @default.
• W4200012968 hasLocation W42000129681 @default.
• W4200012968 hasLocation W42000129682 @default.
• W4200012968 hasOpenAccess W4200012968 @default.
• W4200012968 hasPrimaryLocation W42000129681 @default.
• W4200012968 hasRelatedWork W1577251610 @default.
• W4200012968 hasRelatedWork W2006586291 @default.
• W4200012968 hasRelatedWork W2994686985 @default.
• W4200012968 hasRelatedWork W3212622766 @default.
• W4200012968 hasRelatedWork W3214249464 @default.
• W4200012968 hasRelatedWork W4281722959 @default.
• W4200012968 hasRelatedWork W4292006139 @default.
• W4200012968 hasRelatedWork W4322742330 @default.
• W4200012968 hasRelatedWork W4376471865 @default.

• next